Eosinophilia in patients infected with human immunodeficiency virus

Journal of Infectious Diseases

Volumn 174, Issue 3, 1996, Pages 615-618

  Cohen, Alan J ^a,b   Steigbigel, Roy T ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHILIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPATHOLOGY; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL;

EID: 0029739952     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.3.615     Document Type: Article

References (15)

1. Zucker-Franklin D. Eosinopenia and eosinophilia. In: Williams WJ, Beulter E, Ersler AJ, Lichtman MA, eds. Hematology. 4th ed. New York: McGraw-Hill, 1990:845-9.
2. Ferrandiz C, Ribera M, Barranco JC, Clotet B, Corenzo JC. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Int J Dermatol 1992;31:193-5.
3. Soeprono FF, Schinella RA. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases. J Am Acad Dermatol 1986;14:1020-2.
4. Drabick JJ, Magill AJ, Smith KJ, Nutman TB, Benson PM. Hypereosinophilic syndrome associated with HIV infection. South Med J 1994; 87:525-9.
5. Smith KJ, Skelton HG, Drabick JJ, McCarthy WF, Wagner KF. Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease. Arch Dermatol 1994;130:119-21.
6. Cohen AJ, Peerschke EIB, Steigbigel RT. A comparison of the Coulter STKS, Coulter S+IV, and manual analysis of white blood cell differential counts in a human immunodeficiency virus-infected population. Am J Clin Pathol 1993;6:611-7.
7. Beeson PB, Bass DA. The eosinophil. Philadelphia: Saunders, 1977.
8. Weller PF. Cytokine regulation of eosinophil function. Clin Immunol Immunopathol 1992;62:555-9.
9. Enokihara J, Kajitani H, Nagashima S, et al. Interleukin-5 activity in sera of patients with eosinophilia. Br J Haematol 1990;75:458-62.
10. Owen WF, Rothenberg ME, Petersen J, et al. Interleukin-5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 1989;170:343-8.
11. Limage AP, Abrams JS, Silver JE, Ottesen EA, Nutman TB. Regulation of parasite-induced eosinophilia: selectively increased interleukin-5 production in helminth infected patients. J Exp Med 1990;172:399-402.
12. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
13. Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-65.
14. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
15. Harris PJ. Eosinophils and AIDS. Med Hypotheses 1993;43:75-6.